A molecular profile in NSCLC patients: How? When? Why?
Getting the right drug to the right patient based upon molecular profiling
Date
08 Oct 2016Session
A molecular profile in NSCLC patients: How? When? Why?Presenters
Jean-Charles SoriaAuthors
J. SoriaAuthor affiliations
- Dept. Of Medicine, Institut de Cancérologie Gustave Roussy, 94805 - Villejuif/FR
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction
Presenter: Fiona Blackhall
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Webcast
Organisation: Local, regional and national
Presenter: Fabrice Barlesi
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides
Conclusions and clinical perspectives
Presenter: Fabrice Barlesi
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides
Clinical application of serial molecular biomarker monitoring
Presenter: Stephen Finn
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides